Abstract:Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80-85% of all patients with lung cancer and 5-year relative overall survival (OS) rate is less than 20%, so that identifying novel diagnostic and prognostic biomarkers is urgently demanded. The present study attempted to identify potential key genes associated with the pathogenesis and prognosis of NSCLC. Methods: Four GEO datasets (GSE18842, GSE19804, GSE43458, and GSE62113) were obtained from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) between NSCLC samples and normal ones were analyzed using limma package, and RobustRankAggreg (RRA) package was used to conduct gene integration. Moreover, Search Tool for the Retrieval of Interacting Genes database (STRING), Cytoscape, and Molecular Complex Detection (MCODE) were utilized to establish protein-protein interaction (PPI) network of these DEGs. Furthermore, functional enrichment and pathway enrichment analyses for DEGs were performed by Funrich and OmicShare. While the expressions and prognostic values of top genes were carried out through Gene Expression Profiling Interactive Analysis (GEPIA) and Kaplan Meier-plotter (KM) online dataset. Results: A total of 249 DEGs (113 upregulated and 136 downregulated) were identified after gene integration. Moreover, the PPI network was established with 166 nodes and 1784 protein pairs. Topoisomerase II alpha (TOP2A), a top gene and hub node with higher node degrees in module 1, was significantly enriched in mitotic cell cycle pathway. In addition, Interleukin-6 (IL-6) was enriched in amb2 integrin signaling pathway. The mitotic cell cycle was the most significant pathway in module 1 with the highest P-value. Besides, five hub genes with high degree of connectivity were selected, including TOP2A, CCNB1, CCNA2, UBE2C, and KIF20A, and they were all correlated with worse OS in NSCLC. Conclusion: The results showed that TOP2A, CCNB1, CCNA2, UBE2C, KIF20A, and IL-6 may be potential key genes, while the mitotic cell cycle pathway may be a potential pathway contribute to progression in NSCLC. Further, it could be used as a new biomarker for diagnosis and to direct the synthesis medicine of NSCLC.

The Depletion of PinX1 Involved in the Tumorigenesis of Non-Small Cell Lung Cancer Promotes Cell Proliferation Via P15/cyclin D1 Pathway

Expression and Clinical Significance of PinX1 Gene in Non-small Cell Lung Cancer

PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis.

Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis

Decreased Expression of Pinx1 Protein is Correlated with Tumor Development and is A New Independent Poor Prognostic Factor in Ovarian Carcinoma

Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway

The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.

Pin2 Telomeric Repeat Factor 1-Interacting Telomerase Inhibitor 1 (pinx1) Inhibits Nasopharyngeal Cancer Cell Stemness: Implication for Cancer Progression and Therapeutic Targeting

Pinx1 Without the G-Patch Motif Suppresses Proliferation, Induces Senescence, but Does Not Inhibit Telomerase Activity in Colorectal Cancer Sw480 Cells

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.

Expression and clinical significance of Pin1 and cyclin D1 in pancreatic carcinoma

PRC1 Promotes Cell Proliferation and Cell Cycle Progression by Regulating P21/p27-Prb Family Molecules and FAK-paxillin Pathway in Non-Small Cell Lung Cancer.

Pinin Associates with Prognosis of Hepatocellular Carcinoma Through Promoting Cell Proliferation and Suppressing Glucose Deprivation-Induced Apoptosis

Inhibition Mechanism of PinX1 Gene on Cancer Stem Cells of Nasopharyngeal Carcinoma

Suppression of PinX1 Resulted in Telomere Dysfunction and Enhanced Radiosensitivity in Osteosarcoma Cell Lines.

Molecular analysis of PinX1 in medulloblastomas.

Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.

Telomerase regulation factor PinX1 inhibits proliferation and invasion of hepatoma cells

Tumor Promoting Function of DUSP10 in Non-Small Cell Lung Cancer is Associated with Tumor-Promoting Cytokines.